WHO ICTRP trial

The effect of cannabis on the appetite in cancer patients

EUCTR2017-000530-54-DK · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2017-000530-54-DK
Public title The effect of cannabis on the appetite in cancer patients
Scientific title The effect of cannibinols in patients with pancreatic cancer in the palliative state - Cannibinols in cancer
Primary sponsor University of Copenhagen
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries Denmark
Conditions Pancreatic cancer MedDRA version: 20.1 Level: LLT Classification code 10037027 Term: Protein-calorie malnutrition System Organ Class: 100000004861 MedDRA version: 20.0 Level: LLT Classification code 10064015 Term: Cancer cachexia System…
Interventions Product Name: Dronnabinol oral administration 25mg/ml Pharmaceutical Form: Oral drops INN or Proposed INN: DRONABINOL CAS Number: 1972-08-3 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number…
Registration date Mar 15, 2017
Target size 32
Secondary IDs VS56151/17000277;56151
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations